Overview
In the life sciences industry, continued enforcement activity has placed a premium on sophisticated legal compliance programs calibrated to a company's risk profile. Our lawyers design, implement, and monitor comprehensive compliance solutions for clients of all types and sizes across the entire spectrum of the life sciences industry.
Backed by a deep bench of lawyers and consultants, we bring a wealth of experience, technical know-how, and a broad perspective on our clients’ specific compliance risks.
Compliance for the Real World
A compliance program is never cookie-cutter. Our clients trust us to design right-sized programs that are consistent with the U.S. Department of Health and Human Services Office of Inspector General’s Seven Elements of Effective Compliance Programs, yet aligned with their real-world operations and risks and adaptable as their business grows. We assess the host of factors that drive these risks and help create the policies, procedures, and communication channels that mitigate them.
Compliance Tailored to Risk
Many of our clients are on the leading edge of technologies so new that the regulatory framework for their products is still evolving. Especially in areas with small patient populations and expensive new therapies, these innovative technologies demand unique relationships with the health care entities administering the products and novel programs to facilitate patient access to lifesaving therapies. As clear guidance from regulatory and enforcement agencies tends to lag behind the demand for these programs, it can be difficult to assess compliance risk as these programs are being implemented. Our clients turn to us to realistically evaluate their risks and build and implement compliance programs that are practical, forward-thinking, and fully supportive of their values and ethics.
Compliance Reflecting the Enforcement Landscape
As government enforcement priorities change in response to market forces, companies are under increased pressure to adjust their compliance policies accordingly. Especially at the state level, privacy, transparency, and price reporting issues are receiving closer scrutiny, with more resources devoted to fraud investigations. We help clients keep up with the enforcement landscape as it evolves and integrate new enforcement realities with their existing compliance structures.
Read less
Focus Areas
Experience
- Developed and reviewed corporate compliance programs for federal contractors and direct and indirect providers of health care services, including manufacturers of drugs, devices, and biologicals.
- Conducted effectiveness reviews of corporate compliance programs, and assisted in the development and implementation of work plans to address opportunities for improvement.
- Developed and delivered training modules on legal and regulatory requirements for federal government contractors across the life sciences spectrum to satisfy annual or compliance training requirements.
Contacts
- Board of Directors / Member of the Firm
- Member of the Firm
- Board of Directors / Member of the Firm
Media
Insights
Insights
- Firm AnnouncementsEpstein Becker Green Fuels West Coast Momentum with Six-Attorney Health Care Team6 minute read
- Media CoverageJames Boiani Quoted in “$42M Rat-Infestation Fine Underscores Sanitation Risks Facing Warehouses”3 minute read
- Media CoverageBradley Merrill Thompson Discusses Clinical Decision Support, Medical Devices, and AI in Yale Video1 minute read
- Blogs
What to Do If the Government Knocks on Your Company’s Door … or Breaks It Down – Speaking of Litigation Podcast
28 minute read - Media CoverageOffice Snapshot: Epstein Becker Green's New Nashville Outpost3 minute read
- Firm AnnouncementsEpstein Becker Green Announces 2023 PromotionsOctober 28, 20225 minute read
- Firm Announcements
Epstein Becker Green’s Amy Dow Honored in Crain’s 2022 Notable Women in Law
2 minute read - Media Coverage
Epstein Becker Green’s Diagnosing Health Care Podcast Featured Among the Top 20 Health & Medical Law Podcasts of 2021 ...
3 minute read